The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Clinical trial NCT06861088 · RECRUITING
Trial details
- NCT number
- NCT06861088
- Sponsor
- Quercis Pharma AG
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-19
- Primary completion
- 2027-10-31
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.